Literature DB >> 19081470

Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma?

Yosuke Inoue1, Kiyoshi Hasegawa, Takeaki Ishizawa, Taku Aoki, Keiji Sano, Yoshifumi Beck, Hiroshi Imamura, Yasuhiko Sugawara, Norihiro Kokudo, Masatoshi Makuuchi.   

Abstract

BACKGROUND: Although portal venous tumor thrombus (PVTT) is regarded as an ominous prognostic factor in patients with hepatocellular carcinoma (HCC), the optimal treatment method for maximizing both safety and long-term outcome has not yet been discussed. We describe a surgical technique in which the venous wall is peeled off from the PVTT.
METHODS: In the peeling off (PO) technique, the portal venotomy was placed after adequate vascular control of portal flow. The PVTT was dissected from the portal venous wall and removed through the opening. Macroscopically residual PVTTs intruding into tiny branches were meticulously extracted. This procedure was compared with the en bloc resection of PVTT. Between 1995 and 2006, 49 patients underwent curative hepatic resections for HCC with macroscopic PVTT; these patients were classified according to whether the PO technique (n = 20) or the en bloc technique (n = 29) had been utilized. Both the short- and long-term results were compared between the 2 groups.
RESULTS: No mortalities occurred in either group. Both the 5-year overall survival and the recurrence-free survival rates of the PO group were comparable with those of the en bloc group (39% vs 41% [P = .90] and 23% vs 18% [P = .89], respectively). No local recurrences or regrowth of the PVTT occurred in either group.
CONCLUSION: Our procedure is useful for removing PVTT extending beyond the bifurcation or into other sectors that should be preserved in terms of liver function and enables a more conservative resection than an en bloc technique without sacrificing curability.

Entities:  

Mesh:

Year:  2009        PMID: 19081470     DOI: 10.1016/j.surg.2008.09.005

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  40 in total

1.  Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging.

Authors:  Tian Yang; Chuan Lin; Jian Zhai; Song Shi; Min Zhu; Nan Zhu; Jun-Hua Lu; Guang-Shun Yang; Meng-Chao Wu
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-10       Impact factor: 4.553

2.  Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resection.

Authors:  Rumi Matono; Shohei Yoshiya; Takashi Motomura; Takeo Toshima; Hiroto Kayashima; Toshiro Masuda; Tomoharu Yoshizumi; Akinobu Taketomi; Ken Shirabe; Yoshihiko Maehara
Journal:  HPB (Oxford)       Date:  2012-02-03       Impact factor: 3.647

3.  Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.

Authors:  Yong-Fa Zhang; Rong-Ping Guo; Ru-Hai Zou; Jing-Xian Shen; Wei Wei; Shao-Hua Li; Han-Yue OuYang; Hong-Bo Zhu; Li Xu; Xiang-Ming Lao; Ming Shi
Journal:  Eur Radiol       Date:  2015-09-22       Impact factor: 5.315

4.  Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion.

Authors:  Hidetoshi Nitta; Toru Beppu; Katsunori Imai; Hiromitsu Hayashi; Akira Chikamoto; Hideo Baba
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

5.  Hepatocellular carcinoma with main portal vein tumor thrombus: a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy.

Authors:  Nan Li; Shuang Feng; Jie Xue; Xu-Biao Wei; Jie Shi; Wei-Xing Guo; Wan-Yee Lau; Meng-Chao Wu; Shu-Qun Cheng; Yan Meng
Journal:  HPB (Oxford)       Date:  2016-05-07       Impact factor: 3.647

6.  A Multidisciplinary Team Approach to the Management of Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Authors:  Shuqun Cheng; Xubiao Wei; Jie Shi; Weixing Guo; Shuang Feng; Jian Zhai; Bin Huang
Journal:  Oncologist       Date:  2020-03-06

7.  The role of three-dimensional imaging in optimizing diagnosis, classification and surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.

Authors:  Xu-Biao Wei; Jie Xu; Nan Li; Ying Yu; Jie Shi; Wei-Xing Guo; Hong-Yan Cheng; Meng-Chao Wu; Wan-Yee Lau; Shu-Qun Cheng
Journal:  HPB (Oxford)       Date:  2015-11-17       Impact factor: 3.647

Review 8.  Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis.

Authors:  Wei Liu; Jian-Guo Zhou; Yi Sun; Lei Zhang; Bao-Cai Xing
Journal:  J Gastrointest Surg       Date:  2015-05-06       Impact factor: 3.452

9.  Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma.

Authors:  T Wang; H S Hu; Y X Feng; J Shi; N Li; W X Guo; J Xue; D Xie; S R Liu; M C Wu; S Q Cheng
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

Review 10.  Surgical treatment of hepatocellular carcinoma.

Authors:  Kiyoshi Hasegawa; Norihiro Kokudo
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.